AstraZeneca picks up an Amgen biologics plant; Soon-Shiong's diagnostics firm makes a buy;

@FierceBiotech: FierceBiotech radio on GSK's latest setback, Kyle Bass' 'truthful irrelevancy,' and Horizon's web presence. More | Follow @FierceBiotech

@JohnCFierce: Four years after a transatlantic slapdown, Merck KGaA will once again seek cladribine OK. Article | Follow @JohnCFierce

@DamianFierce: I hereby endorse this bold, disruptive approach to the language of innovation. More | Follow @DamianFierce

> AstraZeneca ($AZN) is buying a Colorado biologics manufacturing facility from Amgen ($AMGN) as it expands its portfolio of large-molecule therapies. More

> Patrick Soon-Shiong's diagnostics business, NantOmics, bought OncoPlex Diagnostics, a company focused on analyzing tumor cells. News

> Medical device giant Zimmer ($ZMH) is planning to lay off 279 employees when it closes its dental headquarters later this year. Story

Medical Device News

@FierceMedDev: ShiftLab's first device is nearing commercialization. Will it start a low-cost revolution? More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Robotic surgery aspirant receives $4M+ in equity financing. Article | Follow @VarunSaxena2

@EmilyWFierce: JAMA: Women face increased risk for second vaginal mesh surgery 10 years after implant. Article | Follow @EmilyWFierce

> Startup Velico nabs another $15.5M from BARDA for dried plasma tech. Story

> Nipro to buy partner, heart attack prediction imaging upstart Infraredx. Report

> WSJ: Feds to launch power morcellator probe aimed at FDA. Article

Pharma News

@FiercePharma: USDA, poultry producers warn MN officials to expect bird flu resurgenceFierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sun targets Ranbaxy plant in Ireland as it prepares to trim manufacturing network. Article | Follow @EricPFierce

@CarlyHFierce: This date last year, I saved a story on my computer as "GSK Woes." So basically, not much has changed. | Follow @CarlyHFierce

> Boehringer's Ofev, chasing a Roche rival, wins backing from NICE. Story

> AstraZeneca picks up discarded Amgen plant as part of its biologics expansion. Report

> AbbVie scores FDA approval for expanded Humira label. Article

Suggested Articles

Frontage is Growing to Meet All Your Needs! Click Here to Learn About the Next Generation of Frontage.

Cara Care, a digital health startup focused on digestive diseases, raised $7 million to bring its mobile app to more patients in the U.S.

Investors looked past the headline success of Sci-B-Vac, zeroed in on the failure to achieve a secondary objective and sent VBI’s stock down 66%.